How to Document Neurology Patient Visits and Neurological Examination Findings

A practical guide for neurologists, nurse practitioners, and medical scribes covering how to document the neurological examination, complex neurological diagnoses, ancillary test results, and follow-up planning in a way that supports continuity of care and withstands payer review.

Neurology notes are among the most technically demanding in medicine. A cardiology note can describe a murmur in a sentence. A neurology note may need to capture twelve cranial nerve findings, lateralized motor deficits, reflex asymmetries, gait analysis, and the clinical reasoning that ties it all to a diagnosis like relapsing-remitting multiple sclerosis or temporal lobe epilepsy. Then it needs to explain why that diagnosis justifies the requested MRI with gadolinium.

The documentation burden is real. A thorough neurological examination takes 20 to 40 minutes to perform and almost as long to dictate well. Residents learn this the hard way. Experienced neurologists develop templates and habits. This guide is about making those habits explicit.

Why Neurology Documentation Is Different

Most specialty notes follow a predictable structure: chief complaint, history, focused exam, assessment, plan. Neurology adds several layers of complexity.

First, the neurological examination itself is a specialized data set. Findings like "2+ patellar reflex with crossed adductor response" or "finger-to-nose dysmetria with intention tremor, worse on the left" are not self-explanatory to a non-neurologist reviewer. The note needs to make the connection between finding and clinical significance explicit.

Second, neurological diagnoses often require longitudinal context. A single visit note for a patient with Parkinson's disease that doesn't reference the UPDRS scores from prior visits, or the baseline functional status before levodopa was started, tells an incomplete story.

Third, ancillary data is central. EEG, EMG/NCS, MRI brain and spine, LP results, and genetic panels are not peripheral findings to mention in passing. They are primary diagnostic data that should be integrated into the assessment with specific reference to results.

Documenting the Neurological Examination

Mental Status

The mental status examination (MSE) in neurology differs from the psychiatric MSE. It is weighted toward cognitive screening and orientation rather than mood and affect (though those matter for conditions like behavioral variant FTD or post-stroke depression).

Document the following:

Orientation: person, place, time, situation
Attention: forward digit span, serial 7s, or months in reverse (specify which you used)
Language: fluency, comprehension, repetition, naming (especially naming errors suggest anomia worth documenting specifically)
Memory: three-item recall at 5 minutes
Visuospatial function: clock drawing or copy task if relevant
Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE) score when formally administered, with the total score, subscores, and any test accommodations noted

A useful concrete example: Dr. Amara Osei sees a 71-year-old man referred for memory concerns. Her MSE note reads: "MoCA 21/30. Missed 1 on orientation (year), 1 on attention (serial 7s, made 2 errors), 2 on delayed recall, 1 on visuospatial (clock drawing: hands placed at approximately 10 and 2 rather than 10 past 11). Language intact for fluency, comprehension, and naming. No intrusions or confabulations noted." That level of specificity does two things: it supports the diagnostic formulation, and it creates a baseline for longitudinal comparison.

Cranial Nerves

Document all twelve cranial nerves (CN I-XII) with at minimum a statement for each nerve or nerve group. For CN II, include visual acuity if tested (by Snellen chart or near card), visual fields by confrontation, and fundoscopic findings if relevant (noting papilledema, disc pallor, or arteriovenous nicking). For CN III, IV, VI, document extraocular movements in all fields of gaze and note any nystagmus (direction, gaze-evoked vs spontaneous, suppression by fixation). Pupillary examination should include size, symmetry, and direct and consensual responses.

For many outpatient neurology encounters, an intact examination is documented as "CN II-XII intact" with specific notations only for abnormalities. This is acceptable as long as the note reflects that the examination was actually performed.

Abnormal findings require specificity. "Left facial droop" is insufficient. "Flattening of the left nasolabial fold with decreased volitional lip curl and forehead sparing, consistent with upper motor neuron pattern facial weakness" is the kind of documentation that distinguishes a cortical stroke from a Bell's palsy.

Motor Examination

The motor examination should document:

Bulk: atrophy, fasciculations by location
Tone: spasticity, rigidity (cogwheel vs lead pipe), paratonia, flaccidity
Power: Medical Research Council (MRC) grading (0-5/5) by muscle group and side (e.g., shoulder abductors 5/5 bilateral, hip flexors 4+/5 left, 5/5 right)
Drift: pronator drift positive or negative

For a Parkinson's patient, the tone documentation matters: "Cogwheel rigidity at the left wrist, 2/4 on the UPDRS Item 22 scale, mild at rest and moderate with activation." That's different from the lead-pipe rigidity seen in secondary parkinsonism.

Sensory Examination

Document modalities tested and the distribution of any deficit. The sensory examination should specify:

Modalities: light touch, pinprick, temperature, vibration (128 Hz tuning fork), proprioception
Distribution: dermatomal (suggesting radiculopathy), nerve territory (mononeuropathy), stocking-glove (polyneuropathy), hemibody (central), dissociated (suggesting syringomyelia or Brown-Séquard)
Subjective report vs objective testing inconsistency, if present

For a patient with suspected diabetic peripheral neuropathy, document vibration at the great toe (absent vs present with reduced amplitude vs normal), pinprick at the dorsum of the foot, and monofilament testing results by site if you're using the 10-gram Semmes-Weinstein monofilament.

Coordination and Gait

Coordination examination findings to document:

Finger-to-nose: dysmetria (bilateral or unilateral), intention tremor, past-pointing
Heel-to-shin: dyssynergia
Rapid alternating movements (RAM): dysdiadochokinesia
Romberg test: positive (eyes closed causes sway or fall) vs negative

Gait analysis should include:

Base width: narrow vs wide-based
Step length and regularity
Arm swing (absent, reduced, asymmetric)
Cadence, festination, freezing episodes
Tandem gait: ability to perform, observed deviations
Turning: number of steps, en-bloc turning
Timed Up and Go (TUG) in seconds when formally measured

For a patient with progressive supranuclear palsy being differentiated from Parkinson's, documenting "restricted upgaze with square-wave jerks, en-bloc turning requiring 5 steps, absent arm swing bilaterally, retrocollis" gives the note the specificity to support the diagnostic reasoning.

Deep Tendon Reflexes

Use the National Institute of Neurological Disorders and Stroke (NINDS) scale (0-4+) for reflexes. Document at minimum: biceps, triceps, brachioradialis, patellar, Achilles bilaterally. Note asymmetries. Document pathological reflexes: Babinski sign (extensor plantar response), Hoffman sign, clonus (location and beats sustained).

A table format works well for reflexes. "Biceps 2+ bilateral, patellar 3+ right / 2+ left, Achilles absent bilateral, Babinski extensor right, flexor left" is clearer than narrative prose for this data.

Documenting Complex Neurological Diagnoses

Epilepsy

Epilepsy documentation requires more than noting the seizure type. Each visit note for a patient with epilepsy should capture:

Seizure type classification per 2017 ILAE classification (focal onset aware, focal onset impaired awareness, focal to bilateral tonic-clonic, generalized onset tonic-clonic, etc.)
Seizure frequency: number per week or month, any clustering, status epilepticus episodes
Seizure triggers: sleep deprivation, alcohol, missed medications, hormonal cycle
Aura description: epigastric rising sensation, déjà vu, olfactory, visual
Postictal period: duration, confusion, weakness (Todd's paralysis), headache
Anti-seizure medication (ASM) regimen with dose, frequency, and adherence
ASM side effects: cognitive slowing, weight change, mood effects, sedation
Drug levels if obtained (noting whether trough or random, with reference range)
Driving restriction counseling documented if state law applies
Women of reproductive age: folic acid supplementation, teratogenicity discussion, NEAD data if applicable

EEG findings should be referenced by study date and specific findings (e.g., "routine EEG 2026-03-15: interictal epileptiform discharges over right temporal region, F8/T4 maximum, consistent with prior EEG from 2025-07"). Describing only "EEG abnormal" is insufficient.

Fictional example: Dr. Yolanda Reyes sees Miguel T., a 34-year-old with focal temporal lobe epilepsy. Her visit note reads: "Since last visit 3 months ago, patient reports 2 seizure events. Both began with epigastric aura followed by behavioral arrest, lip smacking, and right hand automatisms, lasting approximately 2 minutes. One event occurred after staying up all night. No generalization. No status. Driving restriction counseled per state law; patient continues to rely on public transit. Lacosamide 200mg BID: adherent, level 8.2 mcg/mL (trough, drawn this morning; therapeutic range 2-12 mcg/mL). No side effects reported." That note tells the next covering physician exactly where things stand.

Multiple Sclerosis

Multiple sclerosis (MS) notes require documenting across relapse history, disability trajectory, and disease-modifying therapy (DMT) status.

At each visit:

Expanded Disability Status Scale (EDSS) score with the functional systems contributing to the score
Relapse history since last visit: date of onset, symptoms, treatment (IV methylprednisolone dose, number of days), resolution status
Disease-modifying therapy: agent, dose, route, start date, adherence, and monitoring labs (JC antibody index for natalizumab, CBC and LFTs for interferons, lymphocyte count for fingolimod/siponimod)
MRI findings: reference to study date, comparison to prior, new T2 lesions (number and location), gadolinium-enhancing lesions (number), brain atrophy trend
Symptom review: fatigue (Modified Fatigue Impact Scale if used), spasticity, bladder dysfunction, neuropathic pain, cognitive symptoms
Patient-Determined Disease Steps (PDDS) or Multiple Sclerosis Functional Composite (MSFC) if your practice uses them

Fictional example: Sofía M., a 42-year-old with relapsing-remitting MS, presents for her 6-month DMT monitoring visit. Note excerpt: "No clinical relapses since last visit. Natalizumab infusion 32 (300mg IV every 4 weeks, most recent 2026-04-10). JC antibody index: 1.8 (prior index 1.4 drawn 2025-10). Discussion of elevated JC index and PML risk with patient; patient elects to continue natalizumab with enhanced surveillance MRI (every 3 months). MRI brain with and without contrast (2026-03-28): No new T2 lesions compared to 2025-09 MRI. No gadolinium-enhancing lesions. EDSS 2.5 (minimal difficulty in one functional system, no functional disability). Fatigue MFIS 34/84." That JC index documentation matters for medicolegal and monitoring purposes.

Stroke and TIA

A stroke visit note is highly time-dependent. For acute inpatient documentation, capture:

Time last known well (TLW)
NIHSS score on arrival and at discharge
Imaging: CT/MRI findings with specific territory and size (e.g., "DWI-positive lesion in left MCA territory involving posterior frontal and anterior parietal cortex, estimated volume 18 mL")
Etiology workup: cardiac monitoring, echocardiogram, carotid imaging, hypercoagulable panel, paradoxical embolism evaluation
tPA or thrombectomy: given or not, with reason documented if not given
TOAST classification of stroke subtype (large artery atherosclerosis, cardioembolic, small vessel, other determined, undetermined)
Secondary prevention initiated: antithrombotic therapy, statin, blood pressure target

For transient ischemic attack (TIA) outpatient documentation, the ABCD2 score and associated risk stratification should appear in the assessment. A TIA note that does not explain the workup performed and the rationale for management (e.g., why the patient was admitted vs discharged) is incomplete.

Headache

Headache is the most common reason for neurological consultation and one of the most documented incorrectly. For migraine, the note should capture:

Frequency: number of headache days per month (distinguish migraine days from non-migraine headache days)
Medication overuse: days per month of acute medication use, type of medication
MIDAS (Migraine Disability Assessment Score) or HIT-6 (Headache Impact Test) score when used
Abortive therapy: triptan or CGRP receptor antagonist (dose, route, time to relief, need for second dose)
Preventive therapy: agent, dose, titration schedule, duration at current dose, response
Trigger identification and avoidance strategies documented
For CGRP monoclonal antibody therapy: injection site reactions, response documented monthly

For a patient with chronic migraine (15 or more headache days per month), prior authorization documentation will likely be required for most preventive agents. The note should explicitly document frequency, prior treatments tried (with duration and reason for discontinuation), and functional impact.

Parkinson's Disease

Parkinson's disease visits require systematic tracking across motor and non-motor symptoms and medication timing.

Document:

UPDRS (Unified Parkinson's Disease Rating Scale) Part II (motor activities of daily living, patient-reported) and Part III (motor examination) scores
Medication regimen with precise timing: levodopa dose, carbidopa ratio, dosing interval, and any extended-release formulation
Motor fluctuations: duration of "on" periods, timing of wearing off, predictable vs unpredictable, percentage of waking day in "off"
Dyskinesia: timing (peak dose vs diphasic), body regions affected, functional impact, patient's preference regarding trading dyskinesia for more "on" time
Non-motor symptoms: REM sleep behavior disorder, orthostatic hypotension (documented systolic BP supine vs standing at 1 and 3 minutes), constipation, cognitive status (MoCA), depression/anxiety (GDS or PHQ-9), anosmia, excessive daytime sleepiness (Epworth Sleepiness Scale)
Fall history: number of falls in past 3 months, circumstances, injuries
Physical therapy, occupational therapy, speech therapy involvement documented

Documenting Ancillary Test Results

EEG

An EEG report referenced in a neurology note should capture the following elements from the official reading:

Background rhythm: posterior dominant rhythm (PDR) frequency and reactivity
Abnormal findings: epileptiform discharges (location, morphology, frequency), generalized slowing, focal slowing (location, frequency range)
Provocations: hyperventilation response, photic stimulation response
Sleep architecture if sleep captured: vertex waves, spindles, K-complexes, presence or absence of REM
Clinical correlation statement

In your note, the reference should be specific: "Routine EEG (2026-04-05, 30-minute recording): PDR 9 Hz, reactive. Intermittent left temporal theta slowing (T3/T5). No epileptiform discharges. No ictal activity. Clinical correlation: consistent with left temporal dysfunction, supportive of the localization-related epilepsy hypothesis." Citing the study without integrating the findings is not sufficient.

EMG and Nerve Conduction Studies

Electromyography (EMG) and nerve conduction studies (NCS) produce complex reports. Your note should integrate the key findings without reproducing the entire report. Document:

NCS findings: sensory nerve action potential (SNAP) amplitudes and conduction velocities by nerve; motor compound muscle action potential (CMAP) amplitudes, distal latencies, conduction velocities
EMG needle findings: fibrillations, positive sharp waves, fasciculation potentials by muscle; motor unit action potential (MUAP) morphology; recruitment pattern
Electrodiagnostic conclusion: pattern (e.g., length-dependent sensorimotor polyneuropathy, focal mononeuropathy at elbow, anterior horn cell disease pattern)
Your clinical interpretation: "NCS/EMG (2026-03-22): findings consistent with moderate carpal tunnel syndrome bilaterally, right greater than left. No evidence of cervical radiculopathy or generalized polyneuropathy."

Imaging Correlation

When referencing MRI brain, MRI spine, or CT findings, always include the study date, the ordering institution if not your own, and the specific findings relevant to your clinical question. "MRI normal" is not an acceptable documentation standard. "MRI brain without contrast (2026-01-14, outside institution): no acute infarct, no mass lesion, scattered subcortical white matter T2 hyperintensities of undetermined significance, unchanged from 2024-08 MRI" is.

Medication Management in Neurology

Neurological medications carry specific documentation requirements that go beyond routine prescribing.

Controlled substances in neurology (benzodiazepines for epilepsy, opioids for neuropathic pain, stimulants for hypersomnia) require PDMP query documentation, written treatment agreement references, and risk-benefit assessment at each visit.

ASMs with narrow therapeutic windows: document indication, dose, frequency, and whether drug levels are being monitored and are in therapeutic range. For enzyme-inducing ASMs (carbamazepine, phenytoin, phenobarbital), note if the patient is on concurrent medications that may be affected (oral contraceptives, anticoagulants, immunosuppressants).

Botulinum toxin injections: for cervical dystonia, chronic migraine prevention (PREEMPT protocol), or spasticity, document the injection sites by name, the units injected per site, and the cumulative units in the session. A note that says "Botox injected" without listing the muscles, sites, and units is insufficient for billing and for clinical continuity.

For CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab, eptinezumab): document the loading dose vs maintenance dose, the injection date, any injection site reactions, and the response using a standardized measure.

Follow-Up Planning and Coordination

Every neurology note should close with a clear follow-up interval and the clinical rationale for it. "Follow up in 3 months" is acceptable. "Follow up in 3 months to reassess levodopa dose given fluctuating motor response; patient will call sooner if fall occurs" is better.

Coordination notes matter. If you are co-managing a patient with their primary care physician, document what you are asking the PCP to monitor (e.g., blood pressure in a stroke patient, fasting glucose in a patient on valproate). If you are referring to physical therapy, occupational therapy, speech-language pathology, or neuropsychology, document the referral indication and the question you want the consultant to address.

For patients with progressive conditions, document the discussion of prognosis and goals of care when appropriate. A patient with ALS who is deciding whether to pursue non-invasive ventilation should have the conversation documented in clinical terms, not just a checkbox.

Common Documentation Mistakes

1. Listing cranial nerves without specifying examination method. "CN II-XII intact" should mean you tested each nerve. If you screened rather than tested comprehensively, say so. Inconsistency between documented examination and actual examination is a medicolegal risk.

2. Substituting terminology for data. Writing "patient has Parkinson's disease, doing well" without UPDRS scores or functional status documentation does not support continuity of care or prior authorization for adjunctive therapies.

3. EEG and EMG references without integration. Noting an EEG was done without explaining what it showed and how it affects your clinical reasoning is a missed opportunity and a documentation gap.

4. Generic headache notes. "Patient has migraines, treated with sumatriptan" does not document frequency, disability, medication overuse status, or reason for choosing a preventive therapy. It will not survive prior authorization for CGRP antibody therapy.

5. Undocumented safety counseling. Patients with seizure disorders require counseling on driving restrictions (which vary by state), swimming and bath safety, and workplace modifications. If you counseled the patient and it is not in the note, it did not happen clinically.

6. Missing comparison data. Neurology is a longitudinal specialty. A note that doesn't reference prior EDSS, UPDRS, MoCA, or seizure frequency tells an incomplete story for any reviewer who wasn't there for the prior visit.

A Note on Templating High-Volume Visits

Neurologists who see 20 or more patients per day often rely on templates to maintain documentation quality without spending the evening in the chart. If your practice uses a template-based documentation approach, NotuDocs lets you build visit-type templates (new patient evaluation, epilepsy follow-up, MS monitoring visit) that you fill in from your post-visit notes. The fill-in structure means the AI only populates the fields you give it, without generating findings you didn't observe.

Neurology Documentation Checklist

Mental Status and Cognitive Examination

Orientation, attention, language, memory, visuospatial function documented
MoCA or MMSE score recorded with subscores if formally administered
Cognitive findings linked to diagnostic formulation

Cranial Nerve Examination

All 12 cranial nerves addressed (full testing or screening noted)
Abnormal findings described with specific anatomical and functional detail
Upper vs lower motor neuron pattern distinction documented where relevant

Motor, Sensory, Coordination, Reflexes, and Gait

MRC grading by muscle group and side
Tone quality specified (spasticity, cogwheel rigidity, paratonia, flaccidity)
Sensory modalities and distribution documented
Coordination findings by test (FTN, HTS, RAM, Romberg)
Reflex grade and symmetry per NINDS scale with pathological reflexes noted
Gait description with base width, arm swing, turning, tandem gait, TUG if measured

Diagnosis-Specific Elements

Epilepsy: seizure type (2017 ILAE), frequency, ASM regimen with levels, driving counseling
MS: EDSS, relapse history, DMT monitoring labs, MRI comparison with gadolinium lesion count
Stroke: NIHSS, TOAST classification, imaging territory, secondary prevention plan
Headache: days per month, MIDAS or HIT-6, medication overuse, preventive therapy response
Parkinson's: UPDRS II and III, wearing off pattern, dyskinesia, non-motor symptoms, fall history

Ancillary Data Integration

EEG: study date, background rhythm, specific abnormalities, clinical correlation
EMG/NCS: study date, electrodiagnostic conclusion, clinical integration
MRI/CT: study date, specific findings with comparison to prior imaging

Medications and Safety

Neurological medications documented with dose, frequency, adherence, and relevant drug levels
Botulinum toxin: injection sites by name, units per site, total units
PDMP query documented for controlled substances
Counseling on driving, falls, or activity restrictions documented when applicable

Follow-Up and Coordination

Follow-up interval with clinical rationale
PCP or specialist coordination notes documented
Goals of care or prognosis discussion documented when appropriate